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Abstract
© 2018 Russian Academy of Sciences. All rights reserved. In this work we studied the influence
of phospholipase A2 vurtoxin and its homologue lacking enzymatic activity Vur-S49 isolated
from the venom of steppe viper Vipera ursinii renardi on the amplitude-Temporal parameters of
spontaneous and evoked endplate currents (EPCs) in the neuromuscular junction of frog Rana
ridibunda. The experiments performed showed that both vurtoxin and Vur-S49 reduce the EPC
quantal content. The amplitude and time course of spontaneous (one-quantal) signals remained
unchanged,  suggesting  that  these  proteins  do  not  block  nicotinic  acetylcholine  receptors
(nAChRs) on the postsynaptic membrane. Depressing effect in the presence of enzymatically
inactive Vur-S49 suggested that the decrease in the EPC quantal content under the action of
these proteins could not be explained exclusively by phospholipolytic acivity manifested by
vurtoxin. Relying on our previous data we suggested interaction of the proteins studied with
presynaptic a7 nAChRs. Selective antagonist of a7 nicotinic receptors methyllycaconitine (MLA)
reduced the EPC quantal content as well. Depressing action of MLA on the evoked secretion of
acetylcholine indicates the involvement of  a7 nAChRs in  regulation of  the evoked quantal
secretion in the frog neuromuscular junction. However, the effects of vurtoxin and Vur-S49 on
the EPC quantal  content were unchanged after preliminary incubation of  the nerve-muscle
preparation with M LA. The data obtained suggest that presynaptic actions of the proteins
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